SELLAS Life Sciences Group Logo

SELLAS Life Sciences Group

🇺🇸
SLS
US81642T2096

SELLAS Life Sciences Group is a US-based biopharmaceutical company specializing in the development of innovative cancer therapies. It focuses on novel immuno-oncology agents for the treatment of various types of tumors, with the ultimate goal of improving patient care and outcomes.

Next Quarterly Earnings

Wednesday, November 18, 2026
CW 47
After-Hours
In 83 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 21, 2026

Stock Price

Frequently asked questions

When will SELLAS Life Sciences Group report its next quarterly earnings?

SELLAS Life Sciences Group is scheduled to report its next quarterly earnings on 11/18/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did SELLAS Life Sciences Group last report quarterly earnings?

SELLAS Life Sciences Group last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.05 USD.

How does SELLAS Life Sciences Group stock react to earnings?

Across its last 3 earnings reports, SELLAS Life Sciences Group stock moved by ±13.4% on average the following day. The largest reaction was +25.1% on 05/12/2026; 2 of 3 reactions were positive.

How often has SELLAS Life Sciences Group beaten expectations?

SELLAS Life Sciences Group has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the SELLAS Life Sciences Group earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.06
Actual:
Q2 2026
Missed
Estimate:-$0.05
Actual:-$0.05
Difference:-$0.01
Price reaction (1 day):+6.5 %
Price reaction (7 days):+18.6 %
Q1 2026
Beat
Estimate:-$0.06
Actual:-$0.05
Difference:+$0.01
Price reaction (1 day):+25.1 %
Price reaction (7 days):+45.4 %
Q4 2025
Beat
Estimate:-$0.06
Actual:-$0.05
Difference:+$0.01
Price reaction (1 day):-8.5 %
Price reaction (7 days):-4.8 %
Q2 2025
Beat
Estimate:-$0.08
Actual:-$0.06
Difference:+$0.02
Q1 2025
Beat
Estimate:-$0.08
Actual:-$0.07
Difference:+$0.01

Earnings statistics

Stock reaction to earnings

±13.4%
Avg. next-day move
+25.1%
Largest move (05/12/2026)
66.7%
Share of positive reactions
±22.9%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+5.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
SELLAS Life Sciences Group
Ticker Symbol
SLS
ISIN
US81642T2096
Country
🇺🇸
USA
Sector